These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Long-term therapy of bronchial asthma with ketotifen. European experiences].
    Author: Magnussen H.
    Journal: Schweiz Med Wochenschr; 1980 Feb 09; 110(6):191-5. PubMed ID: 6103579.
    Abstract:
    The results of clinical trials in patients with allergic bronchial asthma performed to demonstrate the therapeutic effect of the newly developed substance Ketotifen are reviewed: 1. In 154 patients the efficacy of ketotifen was superior to the antihistaminic clemastine. 2. The therapeutic value of ketotifen was similar to that of cromoglycate. 3. Ketotifen is a beneficial substance for long-term treatment of bronchial asthma. The main advantage of ketotifen is its prophylactic effect when given orally.
    [Abstract] [Full Text] [Related] [New Search]